Pharmacokinetics of parenteral and oral melperone in man-Reference-Cited by-同舟云学术

Pharmacokinetics of parenteral and oral melperone in man

Published:1982 Issue:2 Volume:23 Page:173-176
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Borgstr�m L.,Larsson H.,Molander L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00545974.pdf

Reference12 articles.

1. Christensen JA, Hernestam S, Buus-Lassen J, Sterner H (1965) Pharmacological and toxicological studies on ?-(4-methylpiperidino)-p-fluorobutyrophenone (FG5111) ? a new neuroleptic agent. Acta Pharmacol Toxicol 23:109?132

2. Nörgård A, Tingsgaard P, Nielsen TL (1967) Buronil ved senil konfusion og uro. (Buronil in senile confusion and anxiety). Nord Psykiatr Tidsskr 21:240?244

3. Härnryd C, Bjerkenstedt L, Lindholm H, Ljungberg L (1974) En kontrollerad klinisk prövning av Buronil och haloperidol vid förvirringstillstånd hos äldre patienter. (A controlled clinical study of Buronil and haloperidol in senile confusion) Nord Psykiatr Tidsskr 28:469?472

4. Haugen T (1967) Buronil®, et nytt butyrophenonderivat ved akutte psykiatriska lidelser. (Buronil, a new butyrophenone derivative in acute psychiatric illnesses) Ugeskr Laeg 129:1194?1197

5. Bjerkenstedt L, Härnryd C, Grimm V, Gullberg B, Sedvall G (1978) A double blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS. Arch Psychiatr Nervenkr 226:157?172

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Pharmacotherapy of Psychosis in Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

3. Low-Potency Antipsychotics: Levomepromazine, Melperon, and Pipamperone;NeuroPsychopharmacotherapy;2022

4. Low-Potency Antipsychotics: Levomepromazine, Melperon, and Pipamperone;NeuroPsychopharmacotherapy;2021

5. Pharmacotherapy of Psychosis in Parkinson’s Disease;NeuroPsychopharmacotherapy;2020-12-21